Filed a patent for "treatment of pediatric cancers using gylcogen synthase kinase form b inhibitors" on Mon, April 3, 2023
Filed a patent for "treatment of pediatric cancers using gylcogen synthase kinase form b inhibitors" on Fri, April 7, 2023
Filed a patent for "methods of treating malignant lymphoproliferative disorders" on Thu, April 27, 2023
